APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain Management Drugs

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

Selected research

Market Analysis & Forecast

Global Pain Management Drugs Market Analysis and Forecast 2026-2032

21 December 2025190 pages

Choose your research edition.

Industry ResearchPain Management Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain Management Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pain Management Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain Management Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain Management Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

Read the full market overview

Report Includes

This report presents an overview of global market for Pain Management Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pain Management Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Pain Management Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pain Management Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pain Management Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pain Management Drugs revenue, projected growth trends, production technology, application and end-user industry.

Pain Management Drugs Segment by Company

GSK

Pfizer

Grunenthal

Sanofi

Bayer

AstraZeneca

Eli Lilly

Endo

Merck

Yunnan Baiyao

Teikoku Seiyaku

Teva

J&J

Assertio Therapeutics

Allergan

Pain Management Drugs Segment by Type

Generic Opioids

Branded Opioids

NSAIDs

Others

Pain Management Drugs Segment by Application

Hospitals

Drugstores

Others

Pain Management Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pain Management Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pain Management Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pain Management Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pain Management Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Generic Opioids Major Player Table 3. Branded Opioids Major Player Table 4. NSAIDs Major Player Table 5. Others Major Player Table 6. Global Pain Management Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Player Table 8. Drugstores Major Player Table 9. Others Major Player Table 10. Pain Management Drugs Industry Trends Table 11. Pain Management Drugs Industry Drivers Table 12. Pain Management Drugs Industry Opportunities and Challenges Table 13. Pain Management Drugs Industry Restraints Table 14. Global Pain Management Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Pain Management Drugs Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Pain Management Drugs Market Share by Region (2021-2026) Table 17. Global Pain Management Drugs Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Pain Management Drugs Market Share by Region (2027-2032) Table 19. Global Pain Management Drugs Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Pain Management Drugs Revenue Market Share by Players (2021-2026) Table 21. Global Pain Management Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pain Management Drugs Key Players Headquarters & Area Served Table 23. Global Pain Management Drugs Players, Product Type & Application Table 24. Global Pain Management Drugs Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Pain Management Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Pain Management Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Pain Management Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Pain Management Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Pain Management Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Pain Management Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Pain Management Drugs Revenue Market Share by Application (2027-2032) Table 37. GSK Company Information Table 38. GSK Business Overview Table 39. GSK Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. GSK Pain Management Drugs Product Portfolio Table 41. GSK Recent Development Table 42. Pfizer Company Information Table 43. Pfizer Business Overview Table 44. Pfizer Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Pfizer Pain Management Drugs Product Portfolio Table 46. Pfizer Recent Development Table 47. Grunenthal Company Information Table 48. Grunenthal Business Overview Table 49. Grunenthal Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Grunenthal Pain Management Drugs Product Portfolio Table 51. Grunenthal Recent Development Table 52. Sanofi Company Information Table 53. Sanofi Business Overview Table 54. Sanofi Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Sanofi Pain Management Drugs Product Portfolio Table 56. Sanofi Recent Development Table 57. Bayer Company Information Table 58. Bayer Business Overview Table 59. Bayer Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Bayer Pain Management Drugs Product Portfolio Table 61. Bayer Recent Development Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. AstraZeneca Pain Management Drugs Product Portfolio Table 66. AstraZeneca Recent Development Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Eli Lilly Pain Management Drugs Product Portfolio Table 71. Eli Lilly Recent Development Table 72. Endo Company Information Table 73. Endo Business Overview Table 74. Endo Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Endo Pain Management Drugs Product Portfolio Table 76. Endo Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Merck Pain Management Drugs Product Portfolio Table 81. Merck Recent Development Table 82. Yunnan Baiyao Company Information Table 83. Yunnan Baiyao Business Overview Table 84. Yunnan Baiyao Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Yunnan Baiyao Pain Management Drugs Product Portfolio Table 86. Yunnan Baiyao Recent Development Table 87. Teikoku Seiyaku Company Information Table 88. Teikoku Seiyaku Business Overview Table 89. Teikoku Seiyaku Pain Management Drugs Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 90. Teikoku Seiyaku Pain Management Drugs Product Portfolio Table 91. Teikoku Seiyaku Recent Development Table 92. Teva Company Information Table 93. Teva Business Overview Table 94. Teva Pain Management Drugs Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 95. Teva Pain Management Drugs Product Portfolio Table 96. Teva Recent Development Table 97. J&J Company Information Table 98. J&J Business Overview Table 99. J&J Pain Management Drugs Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 100. J&J Pain Management Drugs Product Portfolio Table 101. J&J Recent Development Table 102. Assertio Therapeutics Company Information Table 103. Assertio Therapeutics Business Overview Table 104. Assertio Therapeutics Pain Management Drugs Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 105. Assertio Therapeutics Pain Management Drugs Product Portfolio Table 106. Assertio Therapeutics Recent Development Table 107. Allergan Company Information Table 108. Allergan Business Overview Table 109. Allergan Pain Management Drugs Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 110. Allergan Pain Management Drugs Product Portfolio Table 111. Allergan Recent Development Table 112. North America Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Pain Management Drugs Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Pain Management Drugs Revenue by Country (US$ Million) & (2027-2032) Table 126. China Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 127. China Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 128. China Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 129. China Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Pain Management Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Pain Management Drugs Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Pain Management Drugs Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Pain Management Drugs Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Pain Management Drugs Image Figure 2. Global Pain Management Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Management Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Generic Opioids Image Figure 5. Branded Opioids Image Figure 6. NSAIDs Image Figure 7. Others Image Figure 8. Global Pain Management Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pain Management Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Drugstores Image Figure 12. Others Image Figure 13. Global Pain Management Drugs Market Size (US$ Million) & (2021-2032) Figure 14. Global Pain Management Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pain Management Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Pain Management Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pain Management Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pain Management Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pain Management Drugs Revenue Market Share by Type (2021-2032) Figure 21. Global Pain Management Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pain Management Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Pain Management Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Pain Management Drugs Revenue Share by Type (2021-2032) Figure 26. North America Pain Management Drugs Revenue Share by Application (2021-2032) Figure 27. North America Pain Management Drugs Revenue Share by Country (2021-2032) Figure 28. United States Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Pain Management Drugs Revenue Share by Type (2021-2032) Figure 33. Europe Pain Management Drugs Revenue Share by Application (2021-2032) Figure 34. Europe Pain Management Drugs Revenue Share by Country (2021-2032) Figure 35. Germany Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Pain Management Drugs Revenue Share by Type (2021-2032) Figure 45. China Pain Management Drugs Revenue Share by Application (2021-2032) Figure 46. Asia Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Pain Management Drugs Revenue Share by Type (2021-2032) Figure 48. Asia Pain Management Drugs Revenue Share by Application (2021-2032) Figure 49. Asia Pain Management Drugs Revenue Share by Region (2021-2032) Figure 50. Japan Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Pain Management Drugs Revenue Share by Type (2021-2032) Figure 58. SAMEA Pain Management Drugs Revenue Share by Application (2021-2032) Figure 59. SAMEA Pain Management Drugs Revenue Share by Country (2021-2032) Figure 60. Brazil Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Opioids
  • Branded Opioids
  • NSAIDs
  • Others
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • GSK
  • Pfizer
  • Grunenthal
  • Sanofi
  • Bayer
  • AstraZeneca
  • Eli Lilly
  • Endo
  • Merck
  • Yunnan Baiyao
  • Teikoku Seiyaku
  • Teva
  • J&J
  • Assertio Therapeutics
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pain Management Drugs Market by Type
  3. 1.2.1 Global Pain Management Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Generic Opioids
  5. 1.2.3 Branded Opioids
  6. 1.2.4 NSAIDs
  7. 1.2.5 Others
  8. 1.3 Pain Management Drugs Market by Application
  9. 1.3.1 Global Pain Management Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Drugstores
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pain Management Drugs Market Dynamics
  1. 2.1 Pain Management Drugs Industry Trends
  2. 2.2 Pain Management Drugs Industry Drivers
  3. 2.3 Pain Management Drugs Industry Opportunities and Challenges
  4. 2.4 Pain Management Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pain Management Drugs Market Perspective (2021-2032)
  2. 3.2 Global Pain Management Drugs Growth Trends by Region
  3. 3.2.1 Global Pain Management Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pain Management Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Pain Management Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pain Management Drugs Revenue by Players
  2. 4.1.1 Global Pain Management Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Pain Management Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pain Management Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pain Management Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pain Management Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Pain Management Drugs Players, Product Type & Application
  8. 4.5 Global Pain Management Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pain Management Drugs Market CR5 and HHI
  11. 4.6.3 2025 Pain Management Drugs Tier 1, Tier 2, and Tier 3
5 Pain Management Drugs Market Size by Type
  1. 5.1 Global Pain Management Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pain Management Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Pain Management Drugs Revenue Market Share by Type (2021-2032)
6 Pain Management Drugs Market Size by Application
  1. 6.1 Global Pain Management Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pain Management Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Pain Management Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Pain Management Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GSK Pain Management Drugs Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Pain Management Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Pain Management Drugs Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Grunenthal
  14. 7.3.1 Grunenthal Company Information
  15. 7.3.2 Grunenthal Business Overview
  16. 7.3.3 Grunenthal Pain Management Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Grunenthal Pain Management Drugs Product Portfolio
  18. 7.3.5 Grunenthal Recent Developments
  19. 7.4 Sanofi
  20. 7.4.1 Sanofi Company Information
  21. 7.4.2 Sanofi Business Overview
  22. 7.4.3 Sanofi Pain Management Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Pain Management Drugs Product Portfolio
  24. 7.4.5 Sanofi Recent Developments
  25. 7.5 Bayer
  26. 7.5.1 Bayer Company Information
  27. 7.5.2 Bayer Business Overview
  28. 7.5.3 Bayer Pain Management Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bayer Pain Management Drugs Product Portfolio
  30. 7.5.5 Bayer Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Pain Management Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Pain Management Drugs Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 Eli Lilly
  38. 7.7.1 Eli Lilly Company Information
  39. 7.7.2 Eli Lilly Business Overview
  40. 7.7.3 Eli Lilly Pain Management Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly Pain Management Drugs Product Portfolio
  42. 7.7.5 Eli Lilly Recent Developments
  43. 7.8 Endo
  44. 7.8.1 Endo Company Information
  45. 7.8.2 Endo Business Overview
  46. 7.8.3 Endo Pain Management Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Endo Pain Management Drugs Product Portfolio
  48. 7.8.5 Endo Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Pain Management Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Merck Pain Management Drugs Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Yunnan Baiyao
  56. 7.10.1 Yunnan Baiyao Company Information
  57. 7.10.2 Yunnan Baiyao Business Overview
  58. 7.10.3 Yunnan Baiyao Pain Management Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Yunnan Baiyao Pain Management Drugs Product Portfolio
  60. 7.10.5 Yunnan Baiyao Recent Developments
  61. 7.11 Teikoku Seiyaku
  62. 7.11.1 Teikoku Seiyaku Company Information
  63. 7.11.2 Teikoku Seiyaku Business Overview
  64. 7.11.3 Teikoku Seiyaku Pain Management Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Teikoku Seiyaku Pain Management Drugs Product Portfolio
  66. 7.11.5 Teikoku Seiyaku Recent Developments
  67. 7.12 Teva
  68. 7.12.1 Teva Company Information
  69. 7.12.2 Teva Business Overview
  70. 7.12.3 Teva Pain Management Drugs Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Teva Pain Management Drugs Product Portfolio
  72. 7.12.5 Teva Recent Developments
  73. 7.13 J&J
  74. 7.13.1 J&J Company Information
  75. 7.13.2 J&J Business Overview
  76. 7.13.3 J&J Pain Management Drugs Revenue and Gross Margin (2021-2026)
  77. 7.13.4 J&J Pain Management Drugs Product Portfolio
  78. 7.13.5 J&J Recent Developments
  79. 7.14 Assertio Therapeutics
  80. 7.14.1 Assertio Therapeutics Company Information
  81. 7.14.2 Assertio Therapeutics Business Overview
  82. 7.14.3 Assertio Therapeutics Pain Management Drugs Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Assertio Therapeutics Pain Management Drugs Product Portfolio
  84. 7.14.5 Assertio Therapeutics Recent Developments
  85. 7.15 Allergan
  86. 7.15.1 Allergan Company Information
  87. 7.15.2 Allergan Business Overview
  88. 7.15.3 Allergan Pain Management Drugs Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Allergan Pain Management Drugs Product Portfolio
  90. 7.15.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Pain Management Drugs Revenue (2021-2032)
  2. 8.2 North America Pain Management Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Pain Management Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Pain Management Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Pain Management Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Pain Management Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Pain Management Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Pain Management Drugs Revenue by Country
  11. 8.6.1 North America Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pain Management Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Pain Management Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pain Management Drugs Revenue (2021-2032)
  2. 9.2 Europe Pain Management Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pain Management Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pain Management Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pain Management Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pain Management Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pain Management Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pain Management Drugs Revenue by Country
  11. 9.6.1 Europe Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pain Management Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pain Management Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pain Management Drugs Revenue (2021-2032)
  2. 10.2 China Pain Management Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Pain Management Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Pain Management Drugs Revenue by Type (2027-2032)
  5. 10.3 China Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Pain Management Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Pain Management Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Pain Management Drugs Revenue by Application (2027-2032)
  9. 10.5 China Pain Management Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pain Management Drugs Revenue (2021-2032)
  2. 11.2 Asia Pain Management Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pain Management Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pain Management Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pain Management Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pain Management Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pain Management Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pain Management Drugs Revenue by Country
  11. 11.6.1 Asia Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pain Management Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pain Management Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pain Management Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Pain Management Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pain Management Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pain Management Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pain Management Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pain Management Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pain Management Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pain Management Drugs Revenue by Country
  11. 12.6.1 SAMEA Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pain Management Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pain Management Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst